A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
Clinical trial NCT02474589 · COMPLETED
Trial details
- NCT number
- NCT02474589
- Sponsor
- SIGA Technologies
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-19
- Primary completion
- 2016-08-24
- Enrollment
- 449
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.